Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 60.34% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.65% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.37% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | 46.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.24% |
| Dec 31, 2025 | 68.06% |
| Sep 30, 2025 | 25.68% |
| Jun 30, 2025 | -49.31% |
| Mar 31, 2025 | -104.28% |
| Dec 31, 2024 | -59.28% |
| Sep 30, 2024 | -80.63% |
| Jun 30, 2024 | -111.30% |
| Mar 31, 2024 | -100.08% |
| Dec 31, 2023 | -54.01% |
| Sep 30, 2023 | -49.04% |
| Jun 30, 2023 | -4.48% |
| Mar 31, 2023 | -97.58% |
| Dec 31, 2022 | -95.44% |
| Sep 30, 2022 | -149.04% |
| Jun 30, 2022 | -108.34% |
| Mar 31, 2022 | 16.62% |
| Dec 31, 2021 | 30.64% |
| Sep 30, 2021 | 29.02% |
| Jun 30, 2021 | 29.92% |